DIRECTORS
sarina hasan
CBE ‘26
maiya raghu
ECo ‘25
MAYA BUTANI
MOL ‘26
what we do
Through partnership with Office of Technology Licensing, we receive a new key piece of Princeton IP/Technology in the life sciences to work on every semester
We conduct a deep dive on the technology and current research to understand the competitive landscape
We assess commercialization pathways, which include clinical trial requirements, potential partnerships, funding requirements and opportunities, and licensing opportunities
At the end of the semester, we provide a deliverable presentation and comprehensive business plan detailing how the business can be formed and the product brought to market
HIGHLIGHTS
2020-21 (SPRING)
2020-21 (FALL)
2019-2020
The team created a pitch deck about a gene therapy promoter for increased genetic payload and long term expression invented by Professor Esteban Engel (NEU) and will be pitching the deck to leaders in the field in the early Fall Semester (Sep. 2021).
The team finalized a licensing deal for a high-throughput SARS-CoV-2 replicon model invented by Professor Alexander Ploss (MOL) and virtually pitched the deck to multiple biotechnology companies and venture capital firms, collecting invaluable feedback along the way (Dec. 2020).
The team created a complete pitch deck for Professor Alexander Ploss of Molecular Biology’s novel HBV technology and successfully pitched the deck to leaders in the field, collecting valuable feedback along the way (Dec. 2019)
our partners
Princeton Innovation Center BioLabs | Princeton Office of the Dean of Undergraduate Students | Princeton Entrepreneurship Council | Princeton Office of Technology Licensing | New Jersey Health Foundation | Keller Center for Innovation in Engineering Education | Merck | Regeneron | Gilead | Alynylam | Eli Lilly